-
AirlinesKorean LCCs’ international flight recovery remains slow
South Korean budget airlines are seeing a slow recovery in international flights as key routes such as China and Japan have yet ...
Jul 15, 2022 (Gmt+09:00)
-
Foreign exchangeWon may head to 1,400 against the dollar for 1st time since 2008-09 crisis
The South Korean won is expected to weaken to 1,400 against the dollar, a level not seen since the 2008-09 global financial cris...
Jul 15, 2022 (Gmt+09:00)
-
Private equityAffirma’s bolt-on M&A strategy shines in S.Korea
Affirma Capital is a small player in South Korea’s private equity market, but its successful bolt-on strategy helps the mi...
Jul 15, 2022 (Gmt+09:00)
-
Future mobilityHyundai, Kia to launch Level 3 self-driving Genesis G90, EV9 in 2023
South Korea’s Hyundai Motor Group will launch its most-advanced Level 3 autonomous cars next year, starting with Hyundai M...
Jul 15, 2022 (Gmt+09:00)
-
RoboticsLG stands out among conglomerates in race to strengthen robotics arms
South Korean conglomerates are rushing to nurture their robotics businesses, encouraged by surging demand for robots in the serv...
Jul 15, 2022 (Gmt+09:00)
-
PerspectivesYen’s plunge raising blood pressures in Asia
Episodes of extreme yen weakness don’t tend to go well for Asia. In the late 1990s, early 2010s and today, a sliding yen oft...
Jul 15, 2022 (Gmt+09:00)
-
IPOsKorea’s battery recycling company SebitChem seeks IPO
SebitChem Co., South Korea’s secondary battery recycling company, is seeking an initial public offering, taking advantage ...
Jul 15, 2022 (Gmt+09:00)
-
Venture capitalKB to raise $150 mn India, SE Asia-focused VC fund
KB Investment Co., a venture capital arm of KB Financial Group, is seeking to raise more than 200 billion won ($150 million) in ...
Jul 15, 2022 (Gmt+09:00)
-
Aerospace & DefenseSouth Korea’s Mirae Asset Group bets $100 million on SpaceX
Mirae Asset Securities Co. is poised to invest $100 million in US spacecraft and satellite communication corporation SpaceX.&nbs...
Jul 15, 2022 (Gmt+09:00)
-
Bio & PharmaSK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic d...
Jul 15, 2022 (Gmt+09:00)